The potential of bacteriophages to tackle both conventional and antibiotic-resistant bacterial infections is becoming more widely recognised. As research and clinical interest in phage therapy grows, one important consideration is the use of the combinations of multiple phages (“phage cocktails”), which allow complex infections to be treated while also minimising the emergence of bacterial resistance.
NexaBiome Life Sciences LTD is developing phages as human pharmaceuticals. The Company has a patented technology that allows them to deliver phages in a commercially viable way is working towards taking a product through clinical trials, with a first target exemplifying the technology being diabetic foot infections (DFIs).
Antimicrobial Resistance (AMR) represents one of the top pressing global health threats, as ranked by the World Health Organization (WHO). It refers to when bacteria, viruses, fungi, or parasites no longer respond to antimicrobial medicines and is caused by the overuse or misuse of antibiotics, and the development of new superbugs.
On January 14, Dr Jason Clark had the privilege of giving evidence to a Lords Science and Technology Select Committee hearing on the antimicrobial potential of phages.
Diabetic foot infections (DFIs) are a serious and often overlooked complication of diabetes, affecting up to a third of all diabetic patients globally.
Bacteriophages are a massively diverse group of bacterial viruses and are often cited as the most abundant organisms on the planet.
Bacteriophages have emerged as an innovative solution for the delivery of genes and drugs in cancer therapy.
Bacteriophages have emerged as key solutions to bacterial challenges arising across human, animal, and harvest health.
Artificial intelligence (AI) is revolutionising the pharma and biotech sectors.
In the ever-evolving biotech landscape, the utility and effectiveness of bacteriophages are gaining significant attention for several applications across an expanse of sectors.
Genome editing is a revolutionary area of biological research that involves the insertion, deletion, or modification of DNA within the genome of a living organism, with the goal of better understanding or improving the function of specific genes and their protein counterparts.
Over the past few decades, the global misuse and overuse of antibiotics have led to the emergence of superbugs, a critical component of the antibiotic resistance crisis.
